Nanomedicine News

RSS
MIT Chemical Engineers Design Nanoparticles to Counter Triple-Negative Breast Cancer

MIT Chemical Engineers Design Nanoparticles to Counter Triple-Negative Breast Cancer

Nanopharmaceutical Drug CRLX101 – A Promising New Cancer Treatment

Nanopharmaceutical Drug CRLX101 – A Promising New Cancer Treatment

Heat, Chemotherapeutic Drugs and Nanotech Delivery System May Improve Ovarian Cancer Treatment

Heat, Chemotherapeutic Drugs and Nanotech Delivery System May Improve Ovarian Cancer Treatment

New Report on Global RNAi Technologies and Markets

New Report on Global RNAi Technologies and Markets

Blood Clots Chop Peptides Added Onto Nanomaterials

Blood Clots Chop Peptides Added Onto Nanomaterials

Cerium Oxide Nanocrystals Hold Potential for Nanomedicine

Cerium Oxide Nanocrystals Hold Potential for Nanomedicine

Near-Infrared Laser Heats Gold Nanoparticles to Kill Targeted Cancer Cells

Near-Infrared Laser Heats Gold Nanoparticles to Kill Targeted Cancer Cells

Novel Nanoparticle-Based Smart Hydrogel Holds Promise for Cartilage Regeneration

Novel Nanoparticle-Based Smart Hydrogel Holds Promise for Cartilage Regeneration

NanoMaterials Technology Signs Exclusive Material Supply Agreement with Stehlin Foundation

NanoMaterials Technology Signs Exclusive Material Supply Agreement with Stehlin Foundation

Forecast Report on Printed and Flexible Sensors

Forecast Report on Printed and Flexible Sensors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.